View in EDS HTML Full Text PDF Full Text

Clinical and molecular effects of oral CCR4 antagonist RPT193 in atopic dermatitis: A Phase 1 study.

Saved in:
Bibliographic Details
Title: Clinical and molecular effects of oral CCR4 antagonist RPT193 in atopic dermatitis: A Phase 1 study.
Authors: Bissonnette, Robert1 (AUTHOR), DuBois, Janet2 (AUTHOR), Facheris, Paola3 (AUTHOR), Del Duca, Ester3 (AUTHOR), Kim, Madeline3 (AUTHOR), Correa Da Rosa, Joel3 (AUTHOR), Trujillo, Damian L.4 (AUTHOR), Bose, Swaroop3 (AUTHOR), Pagan, Angel D.3 (AUTHOR), Wustrow, David4 (AUTHOR), Brockstedt, Dirk G.4 (AUTHOR), Wong, Brian4 (AUTHOR), Kassner, Paul D.4 (AUTHOR), Jankicevic, Jasmina4 (AUTHOR), Ho, William4 (AUTHOR), Cheng, Laurence E.4 (AUTHOR), Guttman‐Yassky, Emma3 (AUTHOR) emma.guttman@mountsinai.org
Source: Allergy. Apr2024, Vol. 79 Issue 4, p924-936. 13p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:01054538
DOI:10.1111/all.15949